Related Experiment Video
Updated: Jul 16, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Prevalence of heart disease--United States, 2005
Insights
State-specific data reveal significant disparities in heart disease prevalence, including myocardial infarction (MI) and angina/coronary heart disease (CHD). Public health programs must target disproportionately affected populations to reduce incidence and eliminate health inequities.
Area of Science:
- Cardiovascular epidemiology
- Public health surveillance
- Health disparities research
Background:
- Heart disease remains the leading cause of death and a major cause of disability in the U.S.
- Significant healthcare expenditures are associated with heart disease, with coronary heart disease costing billions annually.
- Previous data lacked state-specific prevalence for heart disease and detailed information on affected populations.
Purpose of the Study:
- To estimate the prevalence of myocardial infarction (MI) and angina/coronary heart disease (CHD) across all U.S. states, DC, Puerto Rico, and USVI.
- To provide the first state-based prevalence estimates for these specific heart conditions.
- To identify and analyze geographic, racial/ethnic, educational, and sex disparities in heart disease prevalence.
Main Methods:
- Analysis of self-reported data from the 2005 Behavioral Risk Factor Surveillance System (BRFSS).
- Utilized data from all 50 states, the District of Columbia (DC), Puerto Rico, and the U.S. Virgin Islands (USVI).
- Focused on estimating prevalence of myocardial infarction (MI) and angina/coronary heart disease (CHD).
Main Results:
- Substantial geographic disparities in the prevalence of MI and angina/CHD were identified.
- Significant racial/ethnic, educational, and sex disparities were observed in heart disease prevalence.
- The study provides the first state-level prevalence data for MI and angina/CHD.
Conclusions:
- Public health programs should prioritize interventions for disproportionately affected populations.
- Addressing health disparities is crucial to lowering heart disease incidence and achieving Healthy People 2010 goals.
- Targeted public health strategies are necessary to combat inequities in heart disease prevalence.
Abstract:
Heart disease has been the leading cause of death in the United States for the past 80 years and is a major cause of disability. Heart disease also results in substantial health-care expenditures; for example, coronary heart disease is projected to cost an estimated 151.6 billion dollars in direct and indirect costs in 2007. Although some self-reported national data are available, state-specific prevalence data for heart disease have not been reported previously. In addition, although racial/ethnic, geographic, and sex differences in death rates for heart disease have been documented, less information has been available regarding the prevalence of persons living with heart disease. To estimate the prevalence of myocardial infarction (MI) and angina/coronary heart disease (CHD) in each of the 50 states, the District of Columbia (DC), Puerto Rico, and the U.S. Virgin Islands (USVI), CDC analyzed self-reported data from the 2005 Behavioral Risk Factor Surveillance System (BRFSS). This report summarizes the results of that analysis and provides the first state-based prevalence estimates of these heart diseases. The results indicated that substantial geographic, racial/ethnic, educational, and sex disparities existed in the prevalence of MI and angina/CHD. To lower the incidence of heart disease and meet the overall Healthy People 2010 goal to eliminate health disparities, public health programs should target disproportionately affected populations.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Coronary Artery Disease III: Clinical Manifestations